PFE · News · 20261001N

Guidance / Outlook

PFIZER INC · 2026-10-01 · Importance 47 · Surprise 60 · In source text

A third-party report said Pfizer raised the lower end of its fiscal 2026 revenue guidance. The report did not specify the revised lower-bound revenue amount or the prior guidance range. The update was reported alongside Pfizer’s second-quarter 2026 results, but the underlying quarterly performance metrics are excluded from this macro and outlook extraction.

Key facts

Impact estimates

metricdirectionstageexpectedbasis
revenuepositiveprobable—Pfizer raised the lower end of its fiscal 2026 revenue guidance.